Description
Erlotinib, marketed under the trade name Tarceva, among others, is a targeted therapy used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It is specifically designed for cancers with certain epidermal growth factor receptor (EGFR) mutations, promoting cancer cell growth. By inhibiting these receptors, Erlotinib helps slow the growth and spread of tumors. It is typically used when other cancer treatments have not been effective.